Outgoing BIO CEO Focuses On Out-Of-Pocket Costs As Solution To Drug Pricing Woes

 
• By Derrick Gingery

In interview with the Pink Sheet, Jim Greenwood also worries about President Trump promoting drug pricing policies that could hinder innovation.

Medical business or prices concept. Making money in pharmaceutical industry or high medical expenses. Also drug dealing, dealer or trade. Dollar sign written with pills spilled from a medicine bottle.
Even if drug prices are flat, there will still be affordability problems if out-of-pocket costs are not addressed, the outgoing BIO CEO said in an interview with the Pink Sheet. • Source: Shutterstock

More from Pricing Debate

More from Market Access